These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22101905)

  • 1. Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures.
    Lussier YA; Stadler WM; Chen JL
    J Am Med Inform Assoc; 2012; 19(2):156-60. PubMed ID: 22101905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiling in cancer from a bioinformatics prospective.
    Gusev Y; Brackett DJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and cancer: Current status and prospective.
    Wu W; Sun M; Zou GM; Chen J
    Int J Cancer; 2007 Mar; 120(5):953-60. PubMed ID: 17163415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
    Fazi F; Blandino G
    Microrna; 2013; 2(2):81. PubMed ID: 25070777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Module network inference from a cancer gene expression data set identifies microRNA regulated modules.
    Bonnet E; Tatari M; Joshi A; Michoel T; Marchal K; Berx G; Van de Peer Y
    PLoS One; 2010 Apr; 5(4):e10162. PubMed ID: 20418949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A network-biology perspective of microRNA function and dysfunction in cancer.
    Bracken CP; Scott HS; Goodall GJ
    Nat Rev Genet; 2016 Dec; 17(12):719-732. PubMed ID: 27795564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
    Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
    Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique MicroRNA signature and clinical outcome of cancers.
    Yu SL; Chen HY; Yang PC; Chen JJ
    DNA Cell Biol; 2007 May; 26(5):283-92. PubMed ID: 17504024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer and microRNAs: therapeutic impact.
    Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
    Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Disease-miRNA Networks Across Different Cancer Types Using SWIM.
    Fiscon G; Conte F; Farina L; Pellegrini M; Russo F; Paci P
    Methods Mol Biol; 2019; 1970():169-181. PubMed ID: 30963493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in cancer: biomarkers, functions and therapy.
    Hayes J; Peruzzi PP; Lawler S
    Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
    PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer microRNAs: from subtype profiling to predictors of response to therapy.
    Chan E; Prado DE; Weidhaas JB
    Trends Mol Med; 2011 May; 17(5):235-43. PubMed ID: 21354374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.
    Buzdin AA; Prassolov V; Zhavoronkov AA; Borisov NM
    Methods Mol Biol; 2017; 1613():53-83. PubMed ID: 28849558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross talk between microRNA and coding cancer genes.
    Kunej T; Godnic I; Horvat S; Zorc M; Calin GA
    Cancer J; 2012; 18(3):223-31. PubMed ID: 22647358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.